CARLISLE, Pa., April 15, 2019 /PRNewswire/ -- Affirming its position as a leader in global education, Dickinson College today announced it has entered into a new partnership with the prestigious study ...

Clinical outcomes in patients age 40 or younger at diagnosis of synchonous metastatic colorectal cancer. Background: Drozitumab is a monoclonal antibody that triggers tumor cell apoptosis by selective ...

A phase Ib/II study of second-line therapy with panitumumab, irinotecan, and everolimus (PIE) in metastatic colorectal cancer with KRAS wild type (WT). This is an ASCO Meeting Abstract from the 2011 ...